Skip to main content
Unit of study_

Neuropharmacology (Advanced) - PCOL3922

Year - 2018

This unit of study builds on pharmacological knowledge acquired in the intermediate PCOL and BMED units of study with a major emphasis on gaining an understanding of neuropharmacology. The neuropharmacology of the major neurotransmitters and their role in neuropsychiatric diseases is explored together with the treatment of conditions such as Alzheimer's disease, movement disorders, stroke, depression, anxiety, epilepsy, pain and schizophrenia. Elective projects relate to current research areas in Pharmacology.

Two 1 hour lectures per week, five 1 hour tutorials, three 3 hour practicals, elective project (equivalent to three 4 hour practicals).

One 2 hour theory exam, tutorial presentation, practical report, lecture quizzes and elective project (100%)

Nestler, EJ, Hyman, SE and Malenka, RC. Molecular Neuropharmacology: A Foundations for Clinical Neuroscience, 2nd ed. McGraw Hill, 2009.

Assumed knowledge
PCOL2011 or (BMED2401 and an additional 12 credit points from BMED240X)


An annual average mark of 70 or above in the previous year




Faculty: Medicine and Health

Semester 2

30 Jul 2018

Department/School: Pharmacology
Study Mode: Normal (lecture/lab/tutorial) day
Census Date: 31 Aug 2018
Unit of study level: Senior
Credit points: 6.0
EFTSL: 0.125
Available for study abroad and exchange: Yes
Faculty/department permission required? No
More details
Unit of Study coordinator: A/Prof Jonathon Arnold
HECS Band: 2
Courses that offer this unit

Non-award/non-degree study If you wish to undertake one or more units of study (subjects) for your own interest but not towards a degree, you may enrol in single units as a non-award student. Cross-institutional study If you are from another Australian tertiary institution you may be permitted to undertake cross-institutional study in one or more units of study at the University of Sydney.

To help you understand common terms that we use at the University, we offer an online glossary.